Miramoon Pharma
Spin-off of the University of the Basque Country and Biogipuzkoa Health Research Institute. Focused on developing First in Class drugs for Neurodegenerative and Rare Diseases. First program in lead optimisation for Retinitis Pigmentosa (RP), and four programs in lead nomination for DMD, DM1, ALS and AD. The lead compounds normalise calcium levels and protect from oxidative stress damage
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
12
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Miramoon Pharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- AL
Araceli Lara López
Postdoctoral Researcher · Science
EmailPhone - AC
Amalia Capilla
Chief Executive Officer · General Business & Management
EmailPhone - AE
Ana Espinosa
Chief Operating Officer · General Business & Management
EmailPhone
Showing 3 of 5 verified contacts
Top roles at Miramoon Pharma
4 distinct titles indexed · top 4 shown.
- 2co-founder
- 1chief executive officer
- 1chief operating officer
- 1postdoctoral researcher
Sign up to unlock all 5 contacts at Miramoon Pharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Miramoon Pharma
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.